The evolving role of transarterial chemoembolization in the management of hepatocellular carcinoma

Georgios Tsoulfas

doi:10.4103/2394-5079.153287

Hepatoma Research ›› 2015, Vol. 1:9 -10. DOI: 10.4103/2394-5079.153287

Editorial

The evolving role of transarterial chemoembolization in the management of hepatocellular carcinoma

Georgios Tsoulfas

Author information +

History +

PDF

Cite this article

Download citation ▾

Georgios Tsoulfas. The evolving role of transarterial chemoembolization in the management of hepatocellular carcinoma. Hepatoma Research, 2015, 1: 9-10 DOI:10.4103/2394-5079.153287

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Bosetti C,La Vecchia C.Hepatocellular carcinoma epidemiology..Best Pract Res Clin Gastroenterol2014;28:753-70

[2]	Yamada R,Kawabata M,Nakamura K.Hepatic artery embolization in 120 patients with unresectable hepatoma..Radiology1983;148:397-401

[3]	Dash A,Pillai MR.Targeted radionuclide therapy - an overview..Curr Radiopharm2013;6:152-80

[4]	Boily G,Lacoursière L,Couture F,Lapointe R,Gervais N.Transarterial embolization therapies for the treatment of hepatocellular carcinoma: CEPO review and clinical recommendations..HPB (Oxford)2015;17:52-65 PMCID:PMC4266441

[5]	Gamblin TC.Downstaging hepatocellular carcinoma prior to liver transplantation..Liver Transpl2005;11:1466-8

[6]	Xue TC,Zhang L,Zhang BH.Transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus: a meta-analysis..BMC Gastroenterol2013;13:60 PMCID:PMC3626696

[7]

Sato Y,Sone M,Sakamoto N,Takahashi M.Tumor response evaluation criteria for HCC (hepatocellular carcinoma) treated using TACE (transcatheter arterial chemoembolization): RECIST (response evaluation criteria in solid tumors) version 1.1 and mRECIST (modified RECIST): JIVROSG-0602.RECIST (response evaluation criteria in solid tumors) version 1.Ups J Med Sci2013;118:16-22 PMCID:PMC3572665